Appeals Court Holds CMS Has Authority to Implement Rule That Lowered Medicare Payments to Off-Campus Clinics
The U.S. Court of Appeals for the District of Columbia ruled that the Centers for Medicare & Medicaid Services (CMS) acted within its statutory authority in implementing its site-neutral payment policy, which reduced payment rates for evaluation and management services at off-campus, hospital-based clinics. The decision was issued on July 17, 2020, in American Hospital Association, et al. v. Azar, D.C. Cir., No. 19-5352.
In an effort to curtail what it views as unnecessary increases in the volume of covered outpatient services at off-campus hospital-based clinics, CMS finalized its “site neutral” rule in November 2018. The site neutral policy reduced payment rates so services provided at off-campus, hospital-based clinics are reimbursed at the same rate as when provided in a physician’s office. CMS estimated that the rule would reduce Medicare’s expenditures by approximately $610 million in 2019 alone.
The American Hospital Association, the Association of American Medical Colleges and approximately 40 hospital systems brought these consolidated actions, claiming that CMS’s rate reduction for off-campus, hospital-based clinics falls outside of the agency’s statutory authority. As discussed in a previous client alert, the district court agreed and vacated the regulation implementing the rate reduction. Shortly after, CMS announced it would reprocess claims paid at the reduced rate under the site neutral policy and filed an appeal.
The appeals court concluded that the regulation rests on a reasonable interpretation of CMS’s statutory authority to adopt “method[s] for controlling unnecessary increases in the volume of covered [outpatient] services.” 42 U.S.C. § 1395l(t)(2)(F). Because the challenged rate cut is a method that falls under paragraph (2)(F), the appeals court found that judicial review of the regulation is precluded by the statute. The judges ruled that “a service-specific, non-budget-neutral rate reduction falls comfortably within the plain text of” the Outpatient Prospective Payment System (OPPS) and reducing the reimbursement rate for a particular OPPS service “readily qualifies, in common parlance, as a ‘method for controlling unnecessary increases in the volume’ of that service.”
While the decision is a win for CMS, hospitals are disappointed and have implored Congress to step in and pass legislation to outlaw the cuts.
This document is intended to provide you with general information regarding AHA v. Azar. The contents of this document are not intended to provide specific legal advice. If you have any questions about the contents of this document or if you need legal advice as to an issue, please contact the attorneys listed or your regular Brownstein Hyatt Farber Schreck, LLP attorney. This communication may be considered advertising in some jurisdictions.
Recent Insights
Read MoreM&A in AEC: The Advisors You Can’t Do Without
Client Alert | March 04, 2026Colorado’s Landmark AI Law Coming Online: What Developers and Deployers Should Know
Client Alert | March 03, 2026FDA Issues Draft “Plausible Mechanism” Guidance
Client Alert | February 25, 2026President Trump Delivers 2026 State of the Union
Client Alert | February 24, 2026Proposed Bill Could Reshape Property Tax Liability for Colorado Hotels
Client Alert | February 24, 2026The Supreme Court Held IEEPA Tariffs Are Invalid: Legal Analysis and What’s Next for Businesses
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.